DNB
58
-2
NI
67
2
APA
37
2
LEG
36
5
CSCO
61
-3
SYF
86
3
GE
58
-2
ABT
53
-3
WY
48
-2
KMB
30
-3
SLG
53
-2
EQIX
63
3
CMI
58
-2
XOM
37
-2
EIX
62
-4
AKAM
61
3
DGX
29
-3
EXPD
39
-11
AMP
54
2
HSY
38
-7
DNB
58
-2
NI
67
2
APA
37
2
LEG
36
5
CSCO
61
-3
SYF
86
3
GE
58
-2
ABT
53
-3
WY
48
-2
KMB
30
-3
SLG
53
-2
EQIX
63
3
CMI
58
-2
XOM
37
-2
EIX
62
-4
AKAM
61
3
DGX
29
-3
EXPD
39
-11
AMP
54
2
HSY
38
-7
Financhill
Back

First Trust Intl Developed Cap Strth ETF Vs. Aligos Therapeutics Industry Stock Comparison

Buy
59

FICS
First Trust Intl Developed Cap Strth ETF

Last Price:
35.01
Seasonality Move:
-0.83%
Buy
75

ALGS
Aligos Therapeutics

Last Price:
34.48
Seasonality Move:
10.65%
Buy
59
First Trust Intl Developed Cap Strth ETF (FICS) is a Buy

Is First Trust Intl Developed Cap Strth ETF a Buy, Sell or Hold?

  • The current First Trust Intl Developed Cap Strth ETF [FICS] share price is $35.54. The Score for FICS is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • FICS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $34.53. The Score for ALGS is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

FICS Stock Price Chart

What is First Trust Intl Developed Cap Strth ETF's stock price today?

  • The First Trust Intl Developed Cap Strth ETF share price today is $35.54
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FICS is experiencing slight selling pressure.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $34.53
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

FICS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 48.79 Sell
Chaikin Money Flow: -3640 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.92 - 35.78) Buy
Bollinger Bands (100): (34.96 - 36.84) Sell

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.71 Buy
Relative Strength Index (14 RSI): 85.17 Buy
Chaikin Money Flow: 491004 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.08 - 27.66) Buy
Bollinger Bands (100): (7.67 - 19.61) Buy

FICS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.78 Sell
20-day SMA: 35.31 Buy
50-day SMA: 35.87 Sell
200-day SMA: 35.26 Buy
8-day EMA: 35.66 Sell
20-day EMA: 35.57 Sell
50-day EMA: 35.72 Sell
200-day EMA: 35.1 Buy

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.48 Buy
20-day SMA: 23.64 Buy
50-day SMA: 14.76 Buy
200-day SMA: 15.86 Buy
8-day EMA: 28.77 Buy
20-day EMA: 23.99 Buy
50-day EMA: 18.16 Buy
200-day EMA: 16.13 Buy

First Trust Intl Developed Cap Strth ETF Earnings Growth & FICS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

First Trust Intl Developed Cap Strth ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):